涉及主动脉弓的胸主动脉腔内修复术中左锁骨下动脉血运重建的腔内技术与外科手术比较
基于血管质量倡议数据库2014年8月至2023年11月因降主动脉胸段动脉瘤或B型主动脉夹层行涉及主动脉弓的胸主动脉腔内修复术并需左锁骨下动脉血运重建的2455例手术,比较腔内技术与外科手术。两组30天死亡率、卒中、脊髓缺血、手臂缺血及8年生存率相似,外科组围术期再干预率更高,腔内组III型内漏相关再干预率更高。
要点
- 在需左锁骨下动脉血运重建的胸主动脉腔内修复术中,腔内技术与外科手术的30天死亡率和卒中率无显著差异。
- 外科组围术期再干预率高于腔内组(10.7% vs 6.1%;OR 1.75;95%CI 1.75-2.45;P<.001)。
- 腔内组因III型内漏行再干预的比例高于外科组(16.7% vs 3.2%;P=.008)。
核心结论
- 对于因降主动脉胸段动脉瘤或B型主动脉夹层行涉及主动脉弓的胸主动脉腔内修复术并需左锁骨下动脉血运重建的患者,腔内技术与外科手术在围术期死亡率、卒中、脊髓缺血、手臂缺血及8年生存率方面相似。
- 外科组围术期主动脉或分支相关再干预率更高,黑人种族、既往动脉瘤修复和冠状动脉疾病是预测因素。
研究设计与样本
- 回顾性队列研究,查询血管质量倡议数据库2014年8月至2023年11月因降主动脉胸段动脉瘤或B型主动脉夹层行涉及主动脉弓的胸主动脉腔内修复术并需左锁骨下动脉血运重建的患者。
- 共纳入2455例胸主动脉腔内修复术,其中外科左锁骨下动脉血运重建1689例(68.8%),腔内技术血运重建31.1%。
- 采用单因素分析和控制潜在混杂因素的多因素分析比较两组30天死亡率、卒中、卒中或死亡、脊髓缺血、围术期及1年再干预和1年生存率。
主要发现
- 外科组与腔内组30天死亡率分别为4.4% vs 4.1%(OR 1.10;95%CI 0.71-1.71;P=.677),无显著差异。
- 外科组与腔内组围术期卒中分别为4.2% vs 4.6%(OR 0.88;95%CI 0.58-1.34;P=.557),无显著差异。
- 外科组与腔内组卒中或死亡分别为7.6% vs 6.5%(OR 1.16;95%CI 0.82-1.64;P=.391),无显著差异。
- 外科组与腔内组脊髓缺血分别为3.6% vs 2.9%(OR 1.26;95%CI 0.76-2.07;P=.365),无显著差异。
- 外科组与腔内组手臂缺血分别为1.1% vs 0.5%(P=.614),无显著差异。
关键数值与推荐
- 外科组与腔内组围术期再干预率分别为10.7% vs 6.1%(OR 1.75;95%CI 1.75-2.45;P<.001)。
- 外科组与腔内组因III型内漏行再干预的比例分别为3.2% vs 16.7%(P=.008)。
- 围术期再干预的预测因素包括黑人种族(OR 1.36;P=.016)、有症状表现(OR 1.66;P=.001)、既往冠状动脉血运重建(OR 1.56;P=.041)和既往动脉瘤修复(OR 1.58;P=.004)。
- 外科组与腔内组1年再干预率分别为13.5% vs 13.9%(P=1.00),无显著差异。
- 外科组与腔内组8年生存率分别为79.5% vs 78.0%(P=.478),无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Left subclavian artery (LSA) revascularization has been recommended for thoracic endovascular aortic repair (TEVAR) that require LSA coverage to achieve adequate seal. The aim of this study is to evaluate the comparative effectiveness of endovascular techniques vs surgical methods for LSA revascularization. METHODS: The Vascular Quality Initiative was queried for patients undergoing TEVAR involving the arch from August 2014 to November 2023. Procedures for descending thoracic aortic aneurysms (DTAAs) and type B aortic dissections (TBADs) were included. Endovascular LSA revascularization techniques (stents, stent grafts, chimneys, fenestrations, stented fenestrations, fenestrated branch, side-arm branched device) and surgical LSA revascularization were compared with respect to 30-day mortality, stroke, stroke or death, spinal cord ischemia, perioperative and 1-year reinterventions, and 1-year survival using both univariate analysis and multivariable analysis controlling for potential confounders. RESULTS: In a total of 2455 TEVAR procedures done for DTAA and TBAD, LSA revascularization was achieved surgically in 68.8% (n = 1689) and by endovascular techniques in 31.1%. Comparing surgical with endovascular LSA revascularization, there were no differences in 30-day mortality (4.4% vs 4.1%; odds ratio [OR], 1.10; 95% confidence interval [CI], 0.71-1.71; P = .677), perioperative stroke (4.2% vs 4.6%; OR, 0.88; 95% CI, 0.58-1.34; P = .557), stroke or death (7.6% vs 6.5%; OR, 1.16; 95% CI, 0.82-1.64; P = .391), spinal cord ischemia (3.6% vs 2.9%; OR, 1.26; 95% CI, 0.76-2.07; P = .365), and arm ischemia (1.1% vs 0.5%, P = .614). Overall perioperative reinterventions related to the thoracic aorta or branches or direct procedureal complications were higher in the surgical group compared with the endovascular group (10.7% vs 6.1%; OR, 1.75; 95% CI, 1.75-2.45; P < .001). However, reinterventions done specifically for type III endoleaks were notably higher in the endovascular group (16.7% vs 3.2%; P = .008). Predictors of perioperative reinterventions were Black race (OR, 1.36; P = .016), symptomatic presentation (OR, 1.66; P = .001), prior coronary revascularization (OR, 1.56; P = .041), and prior aneurysm repair (OR, 1.58; P = .004). One-year reintervention rates (13.5% vs 13.9%; P = 1.00) and 8-year survival (79.5% vs 78.0%; P = .478) were similar between the surgical and endovascular groups. CONCLUSIONS: In this study of over 2400 patients with DTAA or TBAD undergoing TEVAR that required LSA revascularization, endovascular techniques and surgical procedures were similar with regards to perioperative mortality, stroke, spinal cord ischemia, arm ischemia, and 8-year survival. Perioperative aorta-related and branch-related reinterventions were higher among the surgical group, with Black race, prior aneurysm repair, and coronary artery disease being predictors. This suggests that although endovascular techniques have been less often employed for LSA revascularization, they have similar outcomes compared with surgical LSA revascularization with lower rates of overall perioperative reinterventions.
引用
- Naazie I, Sandhu H, Dosluoglu H, et al. Endovascular versus surgical left subclavian artery revascularization with thoracic endovascular aortic repair involving the aortic arch. J Vasc Surg. 2025. PMID: 40015608. doi:10.1016/j.jvs.2025.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。